National Institute of Endocrinology "C. I. Parhon"
About National Institute of Endocrinology "C. I. Parhon"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Ambrilia Biopharma, Inc.
2
Crinetics Pharmaceuticals Inc.
2
Eisai Inc.
1
Sparrow Pharmaceuticals
1
Clinical Trials at National Institute of Endocrinology "C. I. Parhon"
During the past decade, National Institute of Endocrinology "C. I. Parhon" conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
2007-04-01
2008-02-01
Completed
65
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
2008-02-01
2009-08-01
Terminated
40
Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials
2018-08-16
2023-06-30
Active, not recruiting
50
An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)
2019-01-15
2020-08-31
Completed
47
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
2018-12-18
2020-08-12
Completed
13
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
2022-03-01
2023-08-15
Recruiting
26
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Endocrinology "C. I. Parhon""
#1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at National Institute of Endocrinology "C. I. Parhon"
According to Clinical.Site data, the most researched conditions in "National Institute of Endocrinology "C. I. Parhon"" are
"Acromegaly" (4 trials), "Cortisol Excess" (1 trials), "Cortisol Overproduction" (1 trials), "Cortisol; Hypersecretion" (1 trials) and "Cushing Disease Due to Increased ACTH Secretion" (1 trials). Many other conditions were trialed in "National Institute of Endocrinology "C. I. Parhon"" in a lesser frequency.
Clinical Trials Intervention Types at National Institute of Endocrinology "C. I. Parhon"
Most popular intervention types in "National Institute of Endocrinology "C. I. Parhon"" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Paltusotine" (2 trials), "Placebo" (2 trials), "C2L-OCT-01 PR, 10 or 20 mg" (1 trials), "C2L-OCT-01 PR, 20 mg" (1 trials) and "C2L-OCT-01 PR, 30 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Institute of Endocrinology "C. I. Parhon"
The vast majority of trials in "National Institute of Endocrinology "C. I. Parhon"" are
6 trials for "All" genders.
Clinical Trials Status at National Institute of Endocrinology "C. I. Parhon"
Currently, there are NaN active trials in "National Institute of Endocrinology "C. I. Parhon"".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in National Institute of Endocrinology "C. I. Parhon",
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in National Institute of Endocrinology "C. I. Parhon", 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".